A Case of Acute Myeloid Leukemia with MOZ::TIF2 Fusion Gene Resulting from a Novel Breakpoint

Read full text
Authors: Toma Suzuki, Masahiro Onozawa, Minoru Kanaya, Takeshi Kondo, Shunsuke Sugimura, Jun Nagai, Keito Yokoyama, Yumika Saito, Shota Yoshida, Shinpei Harada, Keito Suto, Yuta Hasegawa
+4 more Takahide Ara, Hideki Goto, Daigo Hashimoto, Takanori Teshima
Cited by: 1
References: 13

Abstract

We report a rare case of acute myeloid leukemia (AML) harboring an MOZ::TIF2 fusion gene with a previously unreported breakpoint. A 36-year-old man was diagnosed with AML involving inv(8)(p11.2q13). Reverse transcriptase-polymerase chain reaction (RT-PCR) initially failed to detect the conventional MOZ exon16::TIF2 exon14 fusion associated with inv(8)(p11.2q13); however, further sequencing identified a novel breakpoint of MOZ exon14::TIF2 exon12, with an additional shorter transcript lacking TIF2 exon13. MOZ::TIF2-positive AML is extremely rare, with only eight cases previously reported, and adult cases appear to have particularly poor outcomes. Our case highlights the diagnostic challenges and aggressive clinical behavior associated with MOZ::TIF2-rearranged AML.

Fields of Study & Subjects

Acute Myeloid Leukemia Research Chromatin Remodeling and Cancer Retinoids in leukemia and cellular processes

Publication details

Journal / source
Internal Medicine
Publisher
Japanese Society of Internal Medicine
Publication date
1 January 2026
Language
EN